JUICE Pharma Worldwide is a full-service agency with offices in New York City and San Francisco, specializing in synergistic HCP/consumer communications that help Specialty Pharma brands reach their maximum market potential. Offering expertise in new MOAs, biologics, oncology, and rare disorders—supported by insight-based strategy—JUICE is the go-to agency for global multichannel programs customized to the needs of your brand. Our innovative business-building solutions—combined with award-winning creative—guarantee that your specialty/biotech product will receive the attention it deserves. The JUICE Global Network reaches across the Americas, Europe, and Asia-Pacific regions, enabling clients to synergize brand and franchise communications in every major market throughout the world. JUICE is an independently-owned, WBENC-certified company.
Active patients are on a journey to find the treatment that is right for them. With an immersive brand experience spanning print, video mailer, web, mobile app, and interactive visual aid, the BRING IT campaign is a destination to help them on this journey.
Merck came late to the iPad party, but the company has made up the distance by releasing a global template for details using the device.
- The 2017 pipeline report: What to know about next year's launches
- Five things for pharma marketers to know: Monday, November 28, 2016
- Lilly's branded app for Trulicity looks to address adherence
- Five things for pharma marketers to know: Tuesday, November 29, 2016
- Lawmakers cut CME exemption from 21st Century Cures Act
- Boehringer Ingelheim launches gamified support program
- Omnicom merges AgencyRx, Flashpoint and three other agencies to form DDB Health
- No free lunch for docs: Sponsored meals linked to more prescriptions
- Non-profit behind Free Killer Tan wants parents to practice sun safety
- Allergan draws on A-list celebs to drive engagement
- Prescription drug spending rises 9% in 2015, to $324 billion
- As users move to mobile, Google says they made 200 million queries for info about cancer drugs
- Five things for pharma marketers to know: Friday, December 2, 2016
- Mylan CEO defends EpiPen strategy, questions pricing model in the U.S.
- Five things for pharma marketers to know: Thursday, December 1, 2016